IFS appoints Matt Breslin as President, North America
Breslin takes key leadership role amid accelerating demand for Industrial AI in
Breslin joins from Upland Software, a global software company based in the US, where he held the position of Chief Revenue Officer and led global go-to-market functions, including Sales, Marketing, Strategic Alliances, and Customer Success. As President,
Breslin's primary focus will be leading the North American team in achieving IFS's next phase of industry-beating growth across core industries in the region: Manufacturing, Energy, Utilities & Resources, Aerospace & Defense, Construction & Engineering, Service, and Telecommunications. Breslin will be at the helm of driving Industrial AI and cloud adoption across new and existing customers in
"I look forward to welcoming Matt to the team at such a pivotal time for IFS. The industries we serve are actively looking to accelerate their transformation with a future-proof, AI-based platform for growth and innovation. Matt's deep industry expertise and extensive leadership experience developing high performance teams will be instrumental in helping customers to adopt Industrial AI and see fast return on investment." said IFS Chief Revenue Officer,
Prior to joining Upland Software, Breslin held senior leadership roles at Infor, SAP and Oracle. Breslin takes over the position from
IFS Press Contacts:
Adam Gillbe
IFS, Director of Corporate & Executive Communications
Email: [email protected]
IFS, Director of Corporate & Executive Communications
Email: [email protected]
This information was brought to you by Cision http://news.cision.com.
The following files are available for download:
https://mb.cision.com/Public/855/4110110/aca685ced90d7358_org.png | MattBv2-930x423px |
View original content:https://www.prnewswire.com/news-releases/ifs-appoints-matt-breslin-as-president-north-america-302383303.html
SOURCE IFS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- University of Utah and U.S. Army Reserve complete historic land transfer and relocation
- Life Peptides Launches Company-Wide Transparency Initiative to Advance Research Peptide Quality and Buyer Education
- RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share